Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M1 PAM Chemotype
Main Authors: | Lisa Barbaro, Alice L. Rodriguez, Ashlyn N. Blevins, Jonathan W. Dickerson, Natasha Billard, Olivier Boutaud, Jerri L. Rook, Colleen M. Niswender, P.Jeffrey Conn, Darren W. Engers, Craig W. Lindsley |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2021-08-01
|
Series: | ACS Bio & Med Chem Au |
Online Access: | https://doi.org/10.1021/acsbiomedchemau.1c00024 |
Similar Items
-
Evaluation of Synthetic Cytochrome P450-Mimetic Metalloporphyrins To Facilitate “Biomimetic” Biotransformation of a Series of mGlu5 Allosteric Ligands
by: Christopher C. Presley, et al.
Published: (2019-07-01) -
A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes
by: Nicole M. Fisher, et al.
Published: (2021-02-01) -
mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists
by: Copani Agata, et al.
Published: (2011-01-01) -
Partial mGlu5 Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG
by: Kimberly M. Holter, et al.
Published: (2021-07-01) -
Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
by: Paulina Cieślik, et al.
Published: (2018-09-01)